During this fireside chat, we welcome MannKind, ticker symbol of MNKD on the NASDAQ and their CEO, Michael Castagna. MannKind focuses on the development and commercialization of inhaled therapeutic products for patients with endocrine and orphan lung diseases.

This Fireside Chat was recorded during the Lytham Partners Fall 2022 Investor Conference.